E-LIB Suche - Ergebnisse für: Dührsen, U.

1

S125: 10-DAY DECITABINE VS. CONVENTIONAL CHEMOTHERAPY ("3 +..:

Lübbert, M. ; Wijermans, P. ; Kicinski, M....
HemaSphere. 6 (2022) - p. 26-27 , 2022

Link: https://doi.org/10.1097/..

2

Cost-Effectiveness of Shortening Treatment Duration Based o..:

Greuter, MJE ; Eertink, JJ ; Jongeneel, G...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) 6 - p. 382-392 , 2022

Link: https://doi.org/10.1016/..

3

Checkpoint immunotherapy of cutaneous squamous cell carcino..:

Jansen, P. ; Lodde, G.C. ; Wetter, A....
Journal of the European Academy of Dermatology and Venereology. 36 (2021) S1 - p. 41-44 , 2021

Link: https://doi.org/10.1111/..

4

PHASED VARIANTS IMPROVE DLBCL MINIMAL RESIDUAL DISEASE DETE..:

Kurtz, D. M ; Chabon, J. J ; Soo, J...
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

5

CLONAL HEMATOPOIESIS IS ASSOCIATED WITH INFERIOR PROGNOSIS ..:

Boegeholz, J ; Alig, S ; Sworder, B...
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

6

Optimal timing and criteria of interim PET in DLBCL: a comp..:

Eertink, J. J. ; Burggraaff, C. N. ; Heymans, M. W....
Blood Advances. 5 (2021) 9 - p. 2375-2384 , 2021

Link: https://doi.org/10.1182/..

7

Sichelzellkrankheit:

Distelmaier, L. ; Dührsen, U. ; Dickerhoff, R.
Der Internist. 61 (2020) 7 - p. 754-758 , 2020

Link: https://doi.org/10.1007/..

8

SAMHD1 IS FREQUENTLY INVOLVED IN T‐CELL PROLYMPHOCYTIC LEUK..:

Johansson, P. ; Klein‐Hitpass, L. ; Bergmann, A.K....
Hematological Oncology. 35 (2017) S2 - p. 164-164 , 2017

Link: https://doi.org/10.1002/..

9

Evolution of NPM1-negative therapy-related myelodysplastic ..:

Herold, S ; Sockel, K ; Sayehli, C...
Leukemia. 31 (2017) 10 - p. 2247-2251 , 2017

Link: https://doi.org/10.1038/..

10

GFI1 as a novel prognostic and therapeutic factor for AML/M..:

Hönes, J M ; Botezatu, L ; Helness, A...
Leukemia. 30 (2016) 6 - p. 1237-1245 , 2016

Link: https://doi.org/10.1038/..

11

Outcomes of diffuse large B-cell lymphoma patients relapsin..:

Van Den Neste, E ; Schmitz, N ; Mounier, N...
Bone Marrow Transplantation. 52 (2016) 2 - p. 216-221 , 2016

Link: https://doi.org/10.1038/..

12

Functional characterization of the ectopically expressed ol..:

Manteniotis, S ; Wojcik, S ; Brauhoff, P...
Cell Death Discovery. 2 (2016) 1 - p. , 2016

Link: https://doi.org/10.1038/..

13

Analyse des Ressourcenverbrauchs und der Kosten in der Nach..:

Meyer, L ; Hörster, L ; Dührsen, U...
Das Gesundheitswesen. 78 (2016) 8/09 - p. , 2016

Link: https://doi.org/10.1055/..

14

Deorphanization and characterization of the ectopically exp..:

Manteniotis, S ; Wojcik, S ; Göthert, J R...
Cell Death Discovery. 2 (2016) 1 - p. , 2016

Link: https://doi.org/10.1038/..

15

72 PERSONALIZED TREATMENT APPROACH FOR GFI136N HETEROZYGOUS..:

Lacramioara, B. ; Makishima, H. ; Michel, L....
Leukemia Research. 39 (2015) - p. S35 , 2015

Link: https://doi.org/10.1016/..